Doctor Arthur Mader
VIVIT Institute, Feldkirch (Austria)
Membership:
ESC Professional Member
Follow
Contributor content
Presentation
Remnant cholesterol is a predictor for all-cause mortality in coronary artery disease patients independent of the total ApoB-particle count
Presentation
Cystatin C predicts mortality in patients with coronary artery disease both among subjects with and among those without the metabolic syndrome
Presentation
The visceral adiposity index predicts the development of type 2 diabetes mellitus in patients with established coronary artery disease
Presentation
Ceramides surpass LDL-cholesterol in predicting cardiovascular mortality in patients with as well as in patients without the metabolic syndrome
Presentation
Three decades of lipid-lowering therapy in type 2 diabetic patients with angiographically proven stable coronary artery disease
Presentation
Cystatin C predicts cardiovascular events in patients with coronary artery disease both among patients with and among those without type 2 diabetes
Presentation
Remnant cholesterol predicts major cardiovascular events in coronary artery disease patients with NAFLD
Presentation
The ceramide-based Coronary Event Risk Test (CERT) predicts cardiovascular mortality in cardiovascular disease patients with type 2 diabetes mellitus as well as in those without diabetes
Presentation
